Literature DB >> 1660059

A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media.

S R White1, G V Kulp, S M Spaethe, E Van Alstyne, A R Leff.   

Abstract

The activity of eosinophil peroxidase (EPO) is commonly employed as a measure of eosinophil activation in biologic fluids. Determination of product formation by this enzyme by end-point measurement may be affected profoundly by substrate concentrations, reaction time and degradation of end-product and enzyme. To determine more accurately EPO concentrations in media conditioned by isolated, purified eosinophils, we have developed a kinetic, colorimetric assay to measure EPO concentration as a function of maximum velocity of reaction (Vmax). An automated method for determining Vmax in a 96-well microplate colorimetric assay was utilized over a wide range of substrate concentrations. Concentrations greater than or equal to 3 x 10(-8) g/ml could be determined reliably with this assay. Peroxidase activity was inhibited in a concentration-dependent manner by the addition of 3-amino-1,2,4-triazole (AMT). The EPO concentration in eosinophils determined by this kinetic method was approximately 1.1 x 10(-5) g/10(6) eosinophils. Eosinophil activation with 10(-6) M f-Met-Leu-Phe (fMLP) caused substantial EPO secretion (9.0 +/- 1.7% vs. 2.9 +/- 0.6% total EPO content for control, P = 0.05) and decrease in eosinophil EPO concentration (92.3 +/- 4.2% of control, P = 0.038). Secretion was enhanced by the addition of 5 micrograms/ml cytochalasin B to 10(-6) M fMLP (25.9 +/- 12.7% total EPO content, P = 0.043 vs. control); similar decreases were noted in eosinophil EPO concentration (71.7 +/- 16.1% of control, P = 0.043). These data demonstrate that determination of EPO secretion by measurement of Vmax is a reliable, accurate method for precise quantification of this enzyme in media containing purified eosinophils or eosinophil products in the absence of other forms of peroxidase activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660059     DOI: 10.1016/0022-1759(91)90094-v

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

2.  Kinetics of eosinophilia and eosinophil activation in the development of non-allergic bronchial hyperresponsiveness in guinea pigs injected with Sephadex beads.

Authors:  K Maghni; M J Simard; D Arseneault; P Sirois
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

3.  Identification of interleukin-2 in human peripheral blood eosinophils.

Authors:  F Levi-Schaffer; J Barkans; T M Newman; S Ying; M Wakelin; R Hohenstein; V Barak; P Lacy; A B Kay; R Moqbel
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

4.  Heparin normalizes allergen-induced nitric oxide deficiency and airway hyperresponsiveness.

Authors:  Harm Maarsingh; Jacob de Boer; Henk F Kauffman; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

5.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Authors:  S R White; M E Strek; G V Kulp; S M Spaethe; R A Burch; S P Neeley; A R Leff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae.

Authors:  David Abraham; Ofra Leon; Silvia Schnyder-Candrian; Chun Chi Wang; Ann Marie Galioto; Laura A Kerepesi; James J Lee; Sara Lustigman
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

7.  Suppression of Eosinophil Integrins Prevents Remodeling of Airway Smooth Muscle in Asthma.

Authors:  Andrius Januskevicius; Reinoud Gosens; Raimundas Sakalauskas; Simona Vaitkiene; Ieva Janulaityte; Andrew J Halayko; Deimante Hoppenot; Kestutis Malakauskas
Journal:  Front Physiol       Date:  2017-01-09       Impact factor: 4.566

8.  The Enhanced Adhesion of Eosinophils Is Associated with Their Prolonged Viability and Pro-Proliferative Effect in Asthma.

Authors:  Andrius Januskevicius; Ieva Janulaityte; Virginija Kalinauskaite-Zukauske; Reinoud Gosens; Kestutis Malakauskas
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

9.  Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma.

Authors:  Andrius Januskevicius; Simona Vaitkiene; Reinoud Gosens; Ieva Janulaityte; Deimante Hoppenot; Raimundas Sakalauskas; Kestutis Malakauskas
Journal:  BMC Pulm Med       Date:  2016-06-13       Impact factor: 3.317

10.  Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity.

Authors:  Rodrigo Jiménez-Saiz; Varun C Anipindi; Heather Galipeau; Yosef Ellenbogen; Roopali Chaudhary; Joshua F Koenig; Melissa E Gordon; Tina D Walker; Talveer S Mandur; Soumeya Abed; Alison Humbles; Derek K Chu; Jonas Erjefält; Kjetil Ask; Elena F Verdú; Manel Jordana
Journal:  Front Immunol       Date:  2020-02-13       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.